Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, has joined a select number of institutions nationwide that offer a specialized chemotherapy delivery system called hepatic artery infusion (HAI) therapy for patients with liver tumors. Cooperman Barnabas Medical Center, an RWJBarnabas Health Facility, is the first in the state of New Jersey to offer this cutting-edge therapy. Read more at cinj.org.
Brett L. Ecker, MD, surgical oncologist and member of RWJBarnabas Health Medical Group and Rutgers Cancer Institute of New Jersey's Division of Surgical Oncology.
Russell Langan, MD, FACS, FSSO, associate chief surgical officer, system integration and quality and director of surgical oncology, Northern Region, RWJBarnabas Health and Rutgers Cancer Institute.